News | October 26, 2010

Study Shows Wi-Fi Signals Affect Heart Rate

October 26, 2010 – Cordless phones, which transmit a similar pulsed signal as Wi-Fi networks at 2.4 gigahertz, have been shown to impact heart rate according to new research published in the European Journal of Oncology.

The study validates the complaints of “electrosensitivity” by increasing numbers of people across the globe, and demonstrated immediate effects on heart rate, in some cases causing it to almost double.

“What we found is what many people have said for a long time about devices that emit microwaves,” said professor Magda Havas, Ph.D., of the environmental and resources studies department at Trent University, Canada, and leader of the study. “People don’t just feel ill, their heart begins to race and this is measurable with medical heart monitoring devices.”??

The volunteers did not know when the phone was on or off and 40 percent of subjects had a moderate to severe reaction only when the phone’s base station was on and emitting microwaves. Those who responded experienced arrhythmia (irregular beats of the heart) and/or tachycardia (rapid heart rate). The symptoms were often accompanied by feelings of pain or pressure in the chest and anxiety that would appear and disappeared for no apparent reason.??

Havas’ study adds to the growing interest in the health effects of cell phones, which also transmit microwave radiation. It also raises serious concern about risks of exposing schoolchildren to Wi-Fi networks, providing a possible explanation for why some children in schools are being diagnosed with, and medicated for, heart irregularities that they believe may linked to Wi-Fi.

“While not everyone who is electrically sensitive responds in this manner, those who do will have difficulty being in environments where microwave radiation is present, which is virtually everywhere in our modern, wireless culture,” Havas said. “Cordless phones and cell phones as well as wireless computers and Wi-Fi networks generate this form of microwave radiation.”??

Additional symptoms include headaches, fatigue, difficulty concentrating, poor short-term memory, difficulty sleeping, skin problems, tinnitus, nausea and dizziness.

For more information: http://electromagnetichealth.org/wp-content/uploads/2010/10/Havas_HRV_Ramazzini1.pdf

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init